{"title":"The impact of open IP platforms on IP-strategy norms in Life Sciences","authors":"Tobias Thornblad, T. Hedner","doi":"10.1504/IJTIP.2012.047378","DOIUrl":null,"url":null,"abstract":"In the biomedical fi eld multiple stakeholders may collaboratively develop, package and build transactions around technology. This is often referred to as open innovation, open biotechnology or open source R&D. Intellectual Property (IP) and IP rights play important roles in collaborative platforms but little research has previously assessed the impact that such platforms exert on corporate IP-strategies. A case study was therefore conducted of the Innovative Medicines Initiative (IMI), CAMBIA Biological Open Source (BiOS) and the Medicines for Malaria Venture (MMV). Our results impact managerial decision-makers at pharmaceutical, biotech and agriscience companies intending to implement corporate open innovation and IP strategies.","PeriodicalId":52540,"journal":{"name":"International Journal of Technology Intelligence and Planning","volume":"43 1","pages":"60"},"PeriodicalIF":0.0000,"publicationDate":"2012-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Intelligence and Planning","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1504/IJTIP.2012.047378","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Decision Sciences","Score":null,"Total":0}
引用次数: 3
Abstract
In the biomedical fi eld multiple stakeholders may collaboratively develop, package and build transactions around technology. This is often referred to as open innovation, open biotechnology or open source R&D. Intellectual Property (IP) and IP rights play important roles in collaborative platforms but little research has previously assessed the impact that such platforms exert on corporate IP-strategies. A case study was therefore conducted of the Innovative Medicines Initiative (IMI), CAMBIA Biological Open Source (BiOS) and the Medicines for Malaria Venture (MMV). Our results impact managerial decision-makers at pharmaceutical, biotech and agriscience companies intending to implement corporate open innovation and IP strategies.
期刊介绍：
The IJTIP is a refereed journal that provides an authoritative source of information in the field of technology intelligence, technology planning, R&D resource allocation, technology controlling, technology decision-making processes and related disciplines.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
